Innate Pharma SA (IPHA)
2.46
+0.06
(+2.50%)
USD |
NASDAQ |
Apr 26, 16:00
Innate Pharma Market Cap: 198.87M for April 26, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 26, 2024 | 198.87M |
| April 25, 2024 | 194.02M |
| April 24, 2024 | 198.87M |
| April 23, 2024 | 191.60M |
| April 22, 2024 | 196.04M |
| April 19, 2024 | 197.25M |
| April 18, 2024 | 189.98M |
| April 17, 2024 | 194.83M |
| April 16, 2024 | 209.38M |
| April 15, 2024 | 195.64M |
| April 12, 2024 | 200.49M |
| April 11, 2024 | 200.49M |
| April 10, 2024 | 203.72M |
| April 09, 2024 | 210.19M |
| April 08, 2024 | 210.19M |
| April 05, 2024 | 204.73M |
| April 04, 2024 | 202.10M |
| April 03, 2024 | 207.76M |
| April 02, 2024 | 203.72M |
| April 01, 2024 | 216.66M |
| March 28, 2024 | 232.82M |
| March 27, 2024 | 192.40M |
| March 26, 2024 | 197.25M |
| March 25, 2024 | 194.02M |
| March 22, 2024 | 191.80M |
| Date | Value |
|---|---|
| March 21, 2024 | 194.84M |
| March 20, 2024 | 202.10M |
| March 19, 2024 | 196.45M |
| March 18, 2024 | 193.21M |
| March 15, 2024 | 204.13M |
| March 14, 2024 | 203.72M |
| March 13, 2024 | 202.10M |
| March 12, 2024 | 210.19M |
| March 11, 2024 | 197.66M |
| March 08, 2024 | 218.27M |
| March 07, 2024 | 211.00M |
| March 06, 2024 | 211.40M |
| March 05, 2024 | 207.76M |
| March 04, 2024 | 212.61M |
| March 01, 2024 | 211.81M |
| February 29, 2024 | 211.81M |
| February 28, 2024 | 213.42M |
| February 27, 2024 | 217.24M |
| February 26, 2024 | 205.34M |
| February 23, 2024 | 215.04M |
| February 22, 2024 | 210.19M |
| February 21, 2024 | 204.53M |
| February 20, 2024 | 209.38M |
| February 16, 2024 | 205.34M |
| February 15, 2024 | 210.19M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
152.40M
Minimum
Dec 16 2022
646.81M
Maximum
May 11 2020
321.45M
Average
275.22M
Median
Jan 26 2023
Market Cap Benchmarks
| Sanofi SA | 122.68B |
| DBV Technologies SA | 131.18M |
| Cellectis SA | 179.36M |
| PHAXIAM Therapeutics SA (DELISTED) | -- |
| Genfit SA | 174.01M |
Market Cap Related Metrics
| PS Ratio | 3.511 |
| Price to Book Value | 3.466 |
| Price | 2.46 |
| Earnings Yield | -3.93% |